Bridge funding through a non-profit partnership to sustain disrupted neurodegenerative research and early career investigators

In response to recent United States federal funding changes, the Alzheimer’s Association and The Michael J. Fox Foundation for Parkinson’s Research, with philanthropic partners, created the Bridge Funding for Disrupted Neurodegenerative research program. Eighteen projects spanning disease risk mechanisms, prevention, basic biology, biomarkers, and population studies were funded, sustaining research momentum and early career scientists during funding uncertainty.

Continued federal and non-profit investment is needed to sustain this progress. We are deeply grateful to our philanthropic partners, without their support this program would not be possible. During the preparation of this Perspective, the authors used ChatGPT, Claude, and Copilot to improve the grammar, syntax, and flow of the text.

After using the tool, the authors reviewed and revised the content as needed and take full responsibility for the publication of this work. Medical and Scientific Relations and Medical Affairs, Alzheimer’s Association, Chicago, IL, USA Oihane Uriarte Huarte, Sarah N. Carrillo Research Business Unit, The Michael J.

Fox Foundation for Parkinson’s Research, New York, New York, USA Olivia Devine, Mark Frasier, Pamela Harrison & Lindsey Riley Correspondence to Oihane Uriarte Huarte. O.U.H., S.N.F., H.M.S. and M.C.C. are full-time employees of the Alzheimer’s Association. O.U.H.’s partner is a postdoctoral researcher at Northwestern University.

H.M.S.’s partner is an employee at Abbott Labs in an unrelated area. M.C.C. has a child who is a graduate student at USC. O.D., P.H., M.F., and L.R. are full-time employees of The Michael J.

Fox Foundation for Parkinson’s Research. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material.